Become a Partner
Our Business Development team invites you to contact them to explore your potential development and commercialization applications using our xMAP® technology.
Click here to start the conversation now.
Luminex Blog
Luminex Licensed Technologies Partner Spotlight: EpiCypher
EpiCypher delivers high-quality reagents for epigenetics and chromatin research
As one of Luminex’s Licensed Technologies Partners, EpiCypher is one of many companies that uses xMAP® Technology to deliver important solutions for improving research and molecular diagnostics. Based out of the Research Triangle Park in North Carolina, EpiCypher is a biotechnology company that helps scientists push the boundaries of research in chromatin regulation, chromatin mapping, and epigenetics.
Continue Reading >
xMAP TECHNOLOGY OVERVIEW
xMAP Technology makes up the basis of Luminex’s core business. This flexible technology is centered on the use of Luminex xMAP Microspheres.
Luminex on Twitter
Latest News
October 22nd
Luminex Corporation Third Quarter Earnings Release Scheduled for November 5, 2020
October 7th
Third Quarter Earnings Call Scheduled for November 2, 2020
September 24th
Luminex Receives BARDA Award to Support 510(k) Filing for NxTAG Respiratory Pathogen Panel That Includes SARS-CoV-2
Events
APHL Newborn Screening Symposium
October 20-November 12
Virtual
ID Week
October 21-25
Virtual
Cytokines 2020
November 1-4
Virtual